6533b826fe1ef96bd1283a05

RESEARCH PRODUCT

LOWER RESPONSE TO INTRAVESICAL ADJUVANT THERAPY IN HIGH-RISK BLADDER CANCER COULD BE RELATED TO THE UROTHELIAL EXPRESSION OF EGFR

Cristina Scalici GesolfoSebastiano BilloneAlessio GuarneriMarco VellaAlessandro PerezGraziella CangemiAntonio RussoAlchiede SimonatoVincenzo Serretta

subject

EGFR bladder cancerSettore MED/24 - Urologiahttp://hdl.handle.net/10447/265441